Due Diligence

The myth of perfection

Kaoru Sakabe
Feb. 1, 2017

With the release of the imaging software Adobe Photoshop in the 1990s, “Photoshopping” entered the English lexicon. Like Google, Photoshop seamlessly has integrated itself into the scientific enterprise. Scientists use the software to tweak images and to generate publication-quality figures. It’s just so easy to create a blemish-free image. But there are guidelines to what is and isn’t acceptable to do with the software. There are a few simple rules to remember.

First, ask yourself whether any changes are needed. The best-case scenario is to be able to present your original, unaltered data in the figure. However, journal editors realize that sometimes the best case isn’t possible — an overly dark H&E stain or an overly bright Coomassie stain of a gel are two examples.

Once you’ve decided it’s appropriate and necessary to make changes, make sure your adjustments are linear. Most journals, including the journals published by the American Society for Biochemistry and Molecular Biology, require that adjustments be made uniformly to every pixel in the entire image. That means using the brightness and contrast functions in Photoshop is acceptable within reason, since these functions apply a linear adjustment to each pixel in the image. Also, go easy on moving the slider (see the figure). Overadjusting the brightness or contrast can hide background features, which is a misrepresentation of your data. Nonlinear adjustments include adjusting the gamma settings or using the “Curves” function in Photoshop. These actions are discouraged, since they do not apply changes equally to the pixels in the image. If these adjustments are used, then you must disclose their use in the figure legend.

Aggressively overadjusting the brightness and/or contrast misrepresents the actual data that were obtained and can mask potential biologically relevant results.Aggressively overadjusting the brightness and/or contrast misrepresents the actual data that were obtained and can mask potential biologically relevant results.

Speaking of data misrepresentation, specifically enhancing, removing or obscuring features would fall into this category. Worried that a faint band won’t support your conclusions? Bothered by the cell debris in the corner of your image? Concerned that the reviewers may say that the co-localization or the co-immunoprecipitation isn’t strong enough? The temptation to enhance or remove these features is real, but this type of manipulation falls into the misconduct category and could have serious consequences.

The final image should look like your original data, warts and all. You always should inspect your final figure and ask yourself if it is a true representation of the original capture or image. If your answer is no (or kind of), you should re-evaluate your figure.

Practically speaking, if any of these issues are discovered during the review of your paper or even after it is published, they could delay publication of your article, result in a correction, or even end in a retraction. More importantly, these issues go deeper and speak about the reproducibility of the work and your integrity as a scientist. Other researchers will not be able to replicate the results shown in your article if some of the data have been enhanced or hidden selectively. Presenting your data in a transparent manner ensures that you have done your due diligence.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Kaoru Sakabe

Kaoru Sakabe is the data integrity manager at the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Seeking the sweet spot to beat a pig parasite
Journal News

Seeking the sweet spot to beat a pig parasite

July 16, 2024

Researchers extracted, separated and tested glycans from the porcine whipworm in an effort to determine the best way to develop treatments and vaccines.

Radioactive drugs strike cancer with precision
News

Radioactive drugs strike cancer with precision

July 14, 2024

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.

Animals have used bioluminescence to communicate for millions of years
News

Animals have used bioluminescence to communicate for millions of years

July 13, 2024

Despite its widespread occurrence, scientists don’t yet know when or where this phenomenon first emerged, or its original function.

Getting to the genetic basis of cardiovascular disease
Journal News

Getting to the genetic basis of cardiovascular disease

July 11, 2024

Edwin G. Peña Martínez received a JBC Tabor award for associating the condition with mutations in noncoding sequences.

Microparticles safeguard vitamins and information
News

Microparticles safeguard vitamins and information

July 9, 2024

Scientists aim to use nanotechnology to combat malnutrition and improve medical recordkeeping in impoverished parts of the world.

Why AlphaFold 3 needs to be open source
Essay

Why AlphaFold 3 needs to be open source

July 7, 2024

The powerful AI-driven software from DeepMind was released without making its code openly available to scientists.